Outlook Therapeutics, Inc. Contracts & Agreements

159 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Syntone Inducement Letter
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Tranche A Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Tranche B Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Syntone Tranche A Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Syntone Tranche B Inducement Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2025
Form of Inducement Letter
Outlook Therapeutics, Inc.
Biotechnology
2025
Description of Registrant's securities
Outlook Therapeutics, Inc.
Biotechnology
2024
Outlook Therapeutics, Inc. Non-Employee Director Compensation Policy, as amended and restated, effective as of October 1, 2024
Compensation Agreements
Outlook Therapeutics, Inc.
Biotechnology
2024
2024 Equity Incentive Plan
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
2024
Form of Stock Option Grant Notice and Stock Option Agreement under the 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
2024
Amendment, dated April 12, 2024, to Sales Agreement, dated May 16, 2023, by and between the Company and BTIG
Sales Agreements
Outlook Therapeutics, Inc.
2024
Form of Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
2024
Form of Syntone Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
Outlook Therapeutics, Inc.
2024
Form of Support Agreement
Outlook Therapeutics, Inc.
2024
Form of Registration Rights Agreement
Registration Rights Agreements
Outlook Therapeutics, Inc.
2024
Syntone Purchase Agreement, dated January 22, 2024
Purchase Agreements
Outlook Therapeutics, Inc.
2024
Syntone Registration Rights Agreement, dated January 22, 2024
Registration Rights Agreements
Outlook Therapeutics, Inc.
2024
Third Amendment to Convertible Promissory Note, dated January 22, 2024
Note Agreements
Outlook Therapeutics, Inc.
2024
Description of Registrants securities
Outlook Therapeutics, Inc.
2023
Outlook Therapeutics, Inc. Non-Employee Director Compensation Policy as Amended and Restated, Effective October 1, 2023
Compensation Agreements
Outlook Therapeutics, Inc.
2023
Amendment, dated December 21, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
2023
At-the-market-sales agreement between the Company and BTIG, LLC dated May 16, 2023
Outlook Therapeutics, Inc.
2023
Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
2023
Description of Registrants securities
Outlook Therapeutics, Inc.
Biotechnology
2022
Outlook Therapeutics, Inc. Non-Employee Director Compensation Policy as Amended and Restated Effective October 1, 2020
Compensation Agreements
Outlook Therapeutics, Inc.
Biotechnology
2022
Form of Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2022
Form of Securities Purchase Agreement, dated as of December 23, 2022, by and between the Company and the Purchasers
Purchase Agreements
Outlook Therapeutics, Inc.
2022
Letter Agreement, dated December 22, 2022, by and between the Company and M.S. Howells & Co
Outlook Therapeutics, Inc.
2022
Securities Purchase Agreement, dated as of December 22, 2022, by and between the Company and Streeterville Capital, LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
UT
2022
Form of Note
Note Agreements
Outlook Therapeutics, Inc.
2022
Amended and Restated Executive Employment Agreement by and between Lawrence Kenyon and Outlook Therapeutics, Inc, dated June 2, 2022
Employment Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2022
Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2022
Executive Employment Agreement by and between Terry Dagnon and Outlook Therapeutics, Inc, dated December 21, 2021
Employment Agreements
Outlook Therapeutics, Inc.
2021
Executive Employment Agreement by and between Jeff Evanson and Outlook Therapeutics, Inc, dated December 21, 2021
Employment Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2021
Amended and Restated Underwriting Agreement, dated November 23, 2021, by and between the Company and H.C. Wainwright & Co., LLC
Underwriting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Form of Underwriter Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2021
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
2021
Promissory Note dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Note Amendment dated November 16, 2021
Note Agreements
Outlook Therapeutics, Inc.
2021
Amendment No.1 to Consulting Agreement between the Company and Scott Three Consulting, LLC (Evanson) dated as of November 8, 2021
Consulting Agreements
Outlook Therapeutics, Inc.
2021
Amendment No. 1 to Consulting Agreement between the Company and The Dagnon Group LLC (Dagnon) dated as of November 8, 2021
Consulting Agreements
Outlook Therapeutics, Inc.
2021
Executive Employment Agreement by and between Lawrence Kenyon and Outlook Therapeutics, Inc, dated July 27, 2021
Employment Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2021
Executive Employment Agreement by and between C. Russell Trenary III and Outlook Therapeutics, Inc, dated July 6, 2021
Employment Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2021
At The Market Offering Agreement between the Company and H.C. Wainwright & Co. dated March 26, 2021
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated February 9, 2021, by and between the Company and GMS Ventures and Investments
Purchase Agreements
Outlook Therapeutics, Inc.
2021
Underwriting Agreement, dated January 28, 2021, by and between the Company and H.C. Wainwright & Co., LLC
Underwriting Agreements
Outlook Therapeutics, Inc.
2021
Form of Underwriter Warrants
Outlook Therapeutics, Inc.
2021
Securities Purchase Agreement, dated January 28, 2021, by and between the Company and Syntone Ventures LLC
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2021
Description of Registrants securities
Outlook Therapeutics, Inc.
2020
Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Promissory Note dated November 4, 2020
Note Agreements
Outlook Therapeutics, Inc.
2020
Lease Termination Agreement dated, May 6, 2020 between the Registrant and Cedar Brook Corporate Center, LP
Lease Agreements
Outlook Therapeutics, Inc.
2020
Form of Placement Agent Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of Securities Purchase Agreement, dated June 22, 2020, by and among the Company and the purchasers named therein
Purchase Agreements
Outlook Therapeutics, Inc.
2020
Securities Purchase Agreement, dated June 22, 2020, by and between the Company and Syntone Ventures LLC
Purchase Agreements
Outlook Therapeutics, Inc.
2020
Engagement Letter, dated June 2, 2020, by and between the Company and H.C. Wainwright & Co., LLC
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Stock Purchase Agreement, dated May 22, 2020, by and between the Company and Syntone Ventures LLC
Stock Agreements
Outlook Therapeutics, Inc.
2020
Form of Common Stock Purchase Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of GMS Stock Purchase Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of Placement Agent Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Form of Securities Purchase Agreement, dated February 24, 2020, by and among the Company and the purchasers named therein
Purchase Agreements
Outlook Therapeutics, Inc.
2020
Securities Purchase Agreement by and between the Company and GMS Ventures and Investments dated February 24, 2020
Purchase Agreements
Outlook Therapeutics, Inc.
2020
Engagement letter dated December 10, 2019 by and between the Company and H.C. Wainwright & Co. LLC
Outlook Therapeutics, Inc.
Biotechnology
NY
2020
Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and...
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Amendment to Warrants to Purchase Common Stock between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020
Stock Agreements
Outlook Therapeutics, Inc.
2020
Agreement to Amend Series A-1 Convertible Preferred between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020
Outlook Therapeutics, Inc.
2020
Termination Agreement and Mutual Release between the Company and MTTR LLC, dated as of January 27, 2020
Termination Agreements
Outlook Therapeutics, Inc.
Biotechnology
CO
2020
Consulting Agreement between the Company and The Dagnon Group LLC (Dagnon), dated as of January 27 2020
Consulting Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2020
Consulting Agreement between the Company and Scott Three Consulting, LLC (Evanson), dated as of January 27, 2020
Consulting Agreements
Outlook Therapeutics, Inc.
2020
Global Amendment, dated as of January 29, 2020
Outlook Therapeutics, Inc.
2020
Exchange Agreement dated December 23, 2019
Exchange Agreements
Outlook Therapeutics, Inc.
2019
Form of Senior Secured Promissory Note
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2019
Amendment #2 dated December 23, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019, as...
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2019
Amendment dated March 4, 2019 of Strategic Partnership Agreement between the Registrant and MTTR LLC effective as of February 15, 2018, as amended
Outlook Therapeutics, Inc.
2019
Third Note Amendment dated June 28, 2019
Note Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2019
Amendment #1 dated June 11, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2019
Amendment dated June 4, 2019 of Strategic Partnership Agreement between the Company and MTTR LLC effective as of February 15, 2018, as amended
Outlook Therapeutics, Inc.
2019
Warrant Agreement, including form of 15-Month Warrant and form of Five-Year Warrant by and between the Registrant and American Stock Transfer & Trust Company, LLC, as Warrant...
Warrant Agreements
Outlook Therapeutics, Inc.
2019
Separation and Release Agreement between the Registrant and Kenneth M. Bahrt, M.D., dated April 23, 2019
Separation Agreements
Outlook Therapeutics, Inc.
2019
Form of Underwriting Agreement
Underwriting Agreements
Outlook Therapeutics, Inc.
2019
Form of Warrant Agreement including form of 15-Month Warrant and form of Five-Year Warrant
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2019
Form of Underwriting Agreement
Underwriting Agreements
Outlook Therapeutics, Inc.
2019
Amendment #3 to the Warrant Agreement dated May 18, 2016, by and between Outlook Therapeutics, Inc. and American Stock Transfer & Trust Company LLC, as Warrant Agent, dated...
Warrant Agreements
Outlook Therapeutics, Inc.
2019
Separation Agreement and Release by and between the Registrant and Stephen J. McAndrew, Ph.D., effective as of November 26, 2018
Separation Agreements
Outlook Therapeutics, Inc.
2018
Strategic Partnership Agreement by and between the Registrant and MTTR, LLC, effective as of February 15, 2018, as amended by the Letter Addendum dated March 2, 2018
Outlook Therapeutics, Inc.
Biotechnology
DE
2018
LEASE TERMINATION AGREEMENT
Lease Agreements
Outlook Therapeutics, Inc.
2018
Purchase Agreement by and between Oncobiologics, Inc. and BioLexis Pte. Ltd., dated November 5, 2018
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2018
Third Amendment to Investor Rights Agreement dated November 5, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
2018
Second Note and Warrant Amendment and Waiver dated November 5, 2018
Warrant Agreements
Outlook Therapeutics, Inc.
2018
Executive Employment Agreement between Oncobiologics, Inc. and Lawrence A. Kenyon, dated October 22, 2018
Employment Agreements
Outlook Therapeutics, Inc.
2018
Term Sheet, Convertible Preferred Equity Investment in Oncobiologics, Inc. by and between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited, dated June 20, 2018
Term Sheets
Outlook Therapeutics, Inc.
2018
Separation Agreement and Release by and between Oncobiologics, Inc. and Pankaj Mohan, Ph.D., dated July 2, 2018
Separation Agreements
Outlook Therapeutics, Inc.
2018
Consulting Agreement by and between Oncobiologics, Inc. and Pankaj Mohan, Ph.D., dated July 2, 2018
Consulting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2018
Exchange Agreement by and between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited, dated July 18, 2018
Exchange Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2018
Second Amendment to Investor Rights Agreement, dated July 18, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Form of Warrant to Purchase Common Stock of Oncobiologics, Inc
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2018
Purchase Agreement by and between Oncobiologics, Inc. and GMS Tenshi Holdings Pte. Limited, dated May 11, 2018
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2018
Amendment to Investor Rights Agreement dated May 11, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
2018
Amendment #2 to the Warrant Agreement dated May 18, 2016 by and between Oncobiologics, Inc. and American Stock Transfer & Trust Company LLC, as Warrant Agent, dated February 9,...
Warrant Agreements
Outlook Therapeutics, Inc.
2018
Sixth Amendment to Lease Agreement by and between Oncobiologics, Inc. and Cedar Brook 7 Corporate Center, LP, dated as of February 1, 2018
Lease Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Form of Warrant to Purchase Common Stock of Oncobiologics, Inc
Warrant Agreements
Outlook Therapeutics, Inc.
2017
Purchase Agreement by and between Oncobiologics, Inc. and the Investor named therein, dated September 7, 2017
Purchase Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2017
Purchase and Exchange Agreement by and between Oncobiologics, Inc. and the Noteholders named therein, dated September 7, 2017
Exchange Agreements
Outlook Therapeutics, Inc.
2017
Investor Rights Agreement by and between Oncobiologics, Inc. and the Investor named therein, dated September 11, 2017
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2017
Form of Voting and Lock-up Agreement by and between the Investor named therein and the Director or Executive Officer of Oncobiologics, Inc. party thereto, dated September 7, 2017
Voting Agreements
Outlook Therapeutics, Inc.
2017
Voting and Lock-up Agreement by and between the Investor named therein and Todd Brady, Director Oncobiologics, Inc., dated September 7, 2017
Voting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2017
Form of Voting and Lock-up Agreement by and between the Investor named therein and the Stockholder of Oncobiologics, Inc. party thereto, dated September 7, 2017
Voting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2017
Form of Voting and Lock-up Agreement by and between the Investor named therein and the Noteholder named therein, dated September 7, 2017
Voting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2017
Lock-up Agreement by and among Oncobiologics, Inc., the Investor named therein and Pankaj Mohan, Ph.D., dated September 7, 2017
Outlook Therapeutics, Inc.
2017
Note, Warrant and Registration Rights Amendment and Waiver, dated September 7, 2017
Warrant Agreements
Outlook Therapeutics, Inc.
2017
Oncobiologics,Inc. FirstAmendment to Note and Warrant Purchase Agreement
Warrant Agreements
Outlook Therapeutics, Inc.
2017
PURCHASE AGREEMENT
Purchase Agreements
Outlook Therapeutics, Inc.
2017
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Outlook Therapeutics, Inc.
2017
AMENDMENT TO WARRANT AGREEMENT ONCOBIOLOGICS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY,LLC, AS WARRANT AGENT
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
2017
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2017
NOTEAND WARRANT PURCHASE AGREEMENT
Warrant Agreements
Outlook Therapeutics, Inc.
2016
securityagreement
Outlook Therapeutics, Inc.
Biotechnology
NY
2016
INTELLECTUALPROPERTY SECURITY AGREEMENT
Security Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
WARRANT AGREEMENT ONCOBIOLOGICS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY,LLC, AS WARRANT AGENT
Warrant Agreements
Outlook Therapeutics, Inc.
2016
SECURITIES PURCHASEAGREEMENT
Outlook Therapeutics, Inc.
2016
Oncobiologics, Inc. [________] Units 1 Each Unit Consisting of One Share of Common Stock ($0.01 par value), One Half of a Series A Warrant to purchaseOne Share of Common Stock and...
Underwriting Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2016
ONCOBIOLOGICS, INC.
Outlook Therapeutics, Inc.
2016
WARRANT AGREEMENT ONCOBIOLOGICS, INC. AND AMERICAN STOCK TRANSFER & TRUST COMPANY,LLC, AS WARRANT AGENT
Warrant Agreements
Outlook Therapeutics, Inc.
2016
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
ONCOBIOLOGICS, INC. Formof Warrant to Purchase Common Stock
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2016
Oncobiologics, Inc. [________] Shares1 Common Stock ($0.01 par value) Underwriting Agreement
Underwriting Agreements
Outlook Therapeutics, Inc.
2016
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
2016
EXECUTIVEEmployment Agreement
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
Amended and Restated Performance StockUnit Agreement
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
ONCOBIOLOGICS, INC. Formof Warrant to Purchase Common Stock
Warrant Agreements
Outlook Therapeutics, Inc.
Biotechnology
NY
2016
CONFIDENTIAL
Outlook Therapeutics, Inc.
2016
Oncobiologics,Inc. 2016 Employee Stock Purchase Plan Adoptedby the Board of Directors: January 28, 2016 Approvedby the Stockholders: January 28, 2016
Stock Agreements
Outlook Therapeutics, Inc.
2016
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
2016
Oncobiologics Inc STOCK INCENTIVE PLAN ArticleI ESTABLISHMENT AND PURPOSES
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
2016
Oncobiologics,Inc. 2015Equity Incentive Plan Adoptedby the Board of Directors: December 4, 2015 Approvedby the Stockholders: December 7, 2015 EffectiveDate: December 4, 2015
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2016
Oncobiologics,Inc. 2015 Equity Incentive Plan StockOption Grant Notice
Bonus & Incentive Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2016
EMPLOYMENTAGREEMENT
Outlook Therapeutics, Inc.
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
Biotechnology
2016
Pankaj Mohan PhD MBA Founder & CEO 7 Clarke Drive, Cranbury New Jersey 08512
Outlook Therapeutics, Inc.
2016
IndemnityAgreement
Outlook Therapeutics, Inc.
2016
CONFIDENTIAL
Outlook Therapeutics, Inc.
2016
AND Oncobiologics, Inc. Commercial License Agreement April 11, 2013
License Agreements
Outlook Therapeutics, Inc.
2016
AND Oncobiologics, Inc. Commercial License Agreement April 11, 2013
License Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
AND Oncobiologics, Inc. Commercial License Agreement April 11, 2013
License Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
JointParticipation Agreement ByAnd Between Oncobiologics,Inc. And ZhejiangHuahai Pharmaceutical Co., Ltd. Effectiveas of May 6 , 2013
Outlook Therapeutics, Inc.
2016
L E A S E A G R E E M E N T
Outlook Therapeutics, Inc.
2016
FIRSTAMENDMENT TO LEASE
Lease Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
SECONDAMENDMENT TO LEASE
Lease Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
THIRDAMENDMENT TO LEASE
Lease Agreements
Outlook Therapeutics, Inc.
2016
FOURTHAMENDMENT TO LEASE
Lease Agreements
Outlook Therapeutics, Inc.
2016
fifthAMENDMENT TO LEASE
Lease Agreements
Outlook Therapeutics, Inc.
Biotechnology
2016
L E AS E A G R E E M E N T
Outlook Therapeutics, Inc.
2016